Results 171 to 180 of about 492,235 (272)

Juvenile idiopathic arthritis presenting with orbital pseudotumor: A rare pediatric association. [PDF]

open access: yesRadiol Case Rep
El Jebbouri K   +6 more
europepmc   +1 more source

DAMPs, PAMPs, and Alarmins: From Mechanism to Therapy

open access: yesMedComm, Volume 7, Issue 9, September 2026.
This review synthesizes the expanding biology of PAMPs and DAMPs, from their molecular sources and sensing mechanisms to regulatory networks that govern inflammation and homeostasis. Spanning from classical immune activation to trained immunity and interorgan communication, we highlight the interplay between PAMPs and DAMPs and their context‐dependent ...
Xuanxuan Yu   +6 more
wiley   +1 more source

Psychological Safety, Medical Trauma and Adaptive Functioning in Long‐Term Conditions: A Multidisciplinary Integrative Approach

open access: yesMultiPsych, Volume 1, Issue 3, September 2026.
ABSTRACT Living with a chronic health condition (CHC) can involve sustained exposure to uncertainty, bodily threat and disruption to identity, relationships and anticipated life trajectories. Although a substantial evidence base exists for psychological interventions in long‐term illness, theoretical accounts remain fragmented across modalities and ...
Liza Morton
wiley   +1 more source

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

open access: yesAllergy, Volume 81, Issue 9, Page 3039-3070, September 2026.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
Franziska Roth‐Walter   +20 more
wiley   +1 more source

Investigating the Short‐Term Changes of the Electrocardiogram Indicators During Hospitalization in Patients With COVID‐19 Following the Use of Tocilizumab

open access: yesAnnals of Noninvasive Electrocardiology, Volume 31, Issue 5, September 2026.
Tocilizumab, an IL‐6 inhibitor used in severe COVID‐19, may have cardiovascular effects. This study examined short‐term electrocardiographic (ECG) changes 24 h before versus 24 h after tocilizumab injection in PCR‐positive COVID‐19 patients. Retrospective study of 33 ICU‐admitted COVID‐19 patients (36.4% male, age 37–79 years). ECG parameters including
Mahdi Zahedi   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy